Emcure Pharmaceuticals Limited announced that its oncology manufacturing facility in Sanand, Ahmedabad has successfully cleared a Pre-Approval Inspection (PAI) conducted by the US Food and Drug ...

No official release date yet, but let’s play detective. Sullivan’s Crossing has been pretty consistent with dropping a new season every year since it started: Season 1 kicked off on CTV in March 2023, ...

Hey, Upload fans! If you’re anything like me, that Season 3 cliffhanger left you reeling, and you’re probably counting down the days until we get some answers in Season 4. The big question on everyone ...

Alright, House of the Dragon fans, let’s talk about Season 3! After that jaw-dropping Season 2 finale, we’re all itching to know what’s next for the Targaryens and their dragon-filled civil war. The ...

In today’s time, India is friendly with several nations. It is unlikely you would name the United States, Japan, Isreal, Bhutan, Afghanistan, Russia. These six nations are having excellent connections ...

The hotel is scheduled to open in November 2025 and will be called Garner Hotel Kyoto Shijo Karasuma, following an extensive interior renovation with strong Kyoto design influences. It will be the ...

Protean eGov Technologies has been eliminated from the Government of India’s PAN 2.0 project, a significant blow for the company that previously expressed confidence in securing the mandate. The Rs ...

Alright, Ginny & Georgia fans, let’s talk about the big question: Is Season 4 of Ginny & Georgia actually happening? After that wild Season 3 finale on Netflix (June 5, 2025, anyone?), we’re all dying ...

Jefferies reiterated its ‘Buy’ rating on the stock with a target price of ₹100, stating that a higher HRAB could significantly enhance allowable tariff recovery and profitability for DIAL, addressing ...

Top USA State 1: Nevada – The Marriage Capital with a Divorce Crisis Nevada has long held a dual reputation: a place where weddings happen at the drop of a hat and divorces are just as easily executed ...

Page Industries shares gained 4% in morning trade after Goldman Sachs initiated a ‘Buy’ rating on the stock with a steep target of ₹52,000. As of 9:58 AM, the shares were trading 2.47% higher at Rs 46 ...

Glenmark Pharmaceuticals has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its entry into the immuno-oncology space. This anti-PD-1 monoclonal antibody, developed by global ...